Home › Relapsing-Remitting Multiple Sclerosis
Pag-aaral pangklinika para sa Relapsing-Remitting Multiple Sclerosis na nagre-recruit sa U.S.
18 pag-aaral para sa Relapsing-Remitting Multiple Sclerosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
Ayos sa estado
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Nagre-recruitPhase 3
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04047628Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05958381Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06408259The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Nagre-recruit
Edad 22 hanggang 60 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06796504Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
Nagre-recruitObservasyonal na pag-aaral
Edad 40 hanggang 70 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07758270Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06864936Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Nagre-recruitPhase 1/2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05359653Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
Nagre-recruit
Edad 45 hanggang 89 · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT06919900Intermittent Hypoxia in Persons With Multiple Sclerosis
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT06276634Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Nagre-recruitPhase 4
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT07225361Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
Nagre-recruit
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT07376772Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Peb 23, 2026 · NCT06390930Effects of Ublituximab on Motor Functions in Multiple Sclerosis
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT06629428Home Based Functional Balance Intervention for Multiple Sclerosis
Nagre-recruit
Edad 40 hanggang 90 · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07355387"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 31, 2025 · NCT07222618Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
Nagre-recruit
Edad 22 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05964829MS-ResearchBiomarkerS
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryoMay bayad para sa mga kalahok
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 6, 2024 · NCT05204459Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hun 6, 2022 · NCT04458688Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.